Neuromodulation of Brain Function in Alzheimer's Disease and Related Dementias

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Early Phase 1
SUMMARY

In this research study we want to learn more about the effects of non-invasive brain stimulation on memory and brain-network function in cognitively unimpaired older adults and in patients with amnestic mild cognitive impairment (aMCI). This study will use a form of non-invasive brain stimulation called repetitive Transcranial Magnetic Stimulation (rTMS). rTMS will slightly alter activity in an area of your brain that controls memory. Changes resulting from this stimulation will be measured with behavioral tests of memory and general cognition, as well as by taking images of your brain with Magnetic Resonance Imaging (MRI). Participants will come in for one baseline visit followed by 10 days of daily rTMS study visits (Monday through Friday) and an evaluation visit. Then, there will be a 2-week break. After this break, they will return for another baseline visit, an additional 10 days of rTMS, and a final evaluation visit.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 99
Healthy Volunteers: t
View:

• Between the ages of 40-99

• Native English speakers

• Willing and able to consent to the protocol and undergo imaging and neuropsychological testing at the specified time points

• Patients with PPA will be asked to bring a study partner to all visits

• Patients with very mild or mild PPA, patients with amnestic mild cognitive impairment and cognitively unimpaired participants with preclinical AD will be included.

Locations
United States
Massachusetts
Massachusetts General Hospital
RECRUITING
Boston
Contact Information
Primary
Alexandra Touroutoglou, PhD
atouroutoglou@mgh.harvard.edu
6176436348
Backup
Anna Du, BA
andu@mgh.harvard.edu
6176436348
Time Frame
Start Date: 2023-05-01
Estimated Completion Date: 2026-03-31
Participants
Target number of participants: 30
Treatments
Experimental: AD, aMCI, lvPPA patients, and preclinical AD
All participants will receive the same study interventions in a within-subject crossover design.
Related Therapeutic Areas
Sponsors
Leads: Massachusetts General Hospital

This content was sourced from clinicaltrials.gov